For instance, targeting NUP98 fusion proteins and their associated proteins with inhibitors that prevent chromatin binding, condensate formation, and oncogene expression represents a potential therapeutic approach for patients with leukemias [135–137]. The gene discussed is NUP98; the disease is leukemia.